Dr. Pritesh R. Mutha, MD, MPH

Dr. Mutha practices at Memorial Hermann Surgery Center Kingsland - Katy (Kingsland Blvd) in Katy, Texas.

Dr. Mutha's NPI, 1386871598, was assigned on June 15, 2009. Dr. Mutha holds Texas license T3831.

Dr. Mutha's primary practice is Memorial Hermann Surgery Center Kingsland - Katy (Kingsland Blvd), at 21720 Kingsland Blvd - Suite 101, Katy, TX 77450. The practice phone is (713) 259-8595.

Dr. Mutha's primary practice is Memorial Hermann Surgery Center Kingsland - Katy (Kingsland Blvd) in Katy, Texas. Dr. Mutha is also affiliated with Memorial Hermann Katy Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Mutha to 1 more hospital, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mutha practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mutha's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Mutha's licenses on file in 3 states: Texas, Pennsylvania and Virginia.

CMS data shows 398 Medicare services from Dr. Mutha across 17 procedure codes in 2024, for 162 Medicare patients. Medicare paid $40,668 for them.

CMS counts 162 Medicare patients who saw Dr. Mutha in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mutha's median patient age at 61, with 57% women.

In 2024, Dr. Mutha wrote 282 Medicare Part D claims for 162 patients. 83% of them were for generic drugs. CMS names the drug for 205 of them, across 5 drugs with 11 or more claims each, at $3,149 in total drug cost. In 2023, CMS named 160 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Mutha for performance year 2024, reported as part of a group. Dr. Mutha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mutha as offering telehealth. CMS counts 236 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mutha, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Mutha, published from 2018 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Barrett Esophagus, Esophageal Neoplasms and Esophagoscopy. Dr. Mutha has published most often in Dig Dis Sci. Dr. Mutha's most frequent co-authors are Tilak Upendra Shah, MD, Alvin M. Zfass, MD and Matthew J. Fasullo, DO.

Dmand AI links Dr. Mutha to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Esophageal Neoplasms and Esophageal Diseases.

CMS Open Payments shows 60 general payments to Dr. Mutha from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Covidien LP paid the most, $1,775. It also lists 6 research payments totaling $377 in 2018.